What is CR's health score?

Crane Co (CR) has a TradeApes health score of 61 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CR's estimated fair value?

Based on our 5-year discounted cash flow model, Crane Co's estimated fair value is $115.43 per share, representing a -36.9% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is CR undervalued or overvalued?

Our model currently rates CR as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CR... Refresh in a moment for the full analysis.

Crane Co (CR)

Industrials Overvalued low healthy

$183.0

Updated: 2026-05-30

TradeApes Score

Financial Strength

85 Strong

Operating Trend

55 Mixed

Relative Value

40 Weak

Capital Allocation

55 Mixed

Risk

80 Strong

Est. Fair Value $115.43

DCF Upside -36.9%

Sector Rank #2567 of 3948

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.